|
|
Office Locations:
|
2 Bethesda Metro Center, Suite 1510
Bethesda, MD 20814
Phone: 301-272-9990
Fax: 301-656-0294
| | |
|
|
|
|
|
Business Services
Life Sciences & Healthcare
|
|
|
|
Northlane Capital Partners invests in growing, highly profitable middle market companies. The firm's four founding partners have worked together since 2003, investing more than $1.6 billion in our target verticals of healthcare and business services. Northlane looks to partner with motivated management teams operating market leading companies in high growth niches. In addition to these characteristics, the firm's ideal target company generates high EBITDA and cash flow margins, and is either recession resistant or has demonstrated a rapid recovery through the business cycle. Northlane looks for platform investments ranging in size from $5 million to $30 million of EBITDA (no minimums for add-ons to existing portfolio companies). Northlane focuses on lower middle market healthcare and business services in North America. The firm targets equity Investments of $25 to $150 million.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
